Pharsight

AMYLIN PHARMACEUTICALS LLC patents facing oppositions

Top patents of AMYLIN PHARMACEUTICALS LLC facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2347762B1 08 May, 2019 Exendin for treating diabetes and reducing body weight Aug, 2026 2
EP2341905B2 13 Sep, 2023 Sustained release formulations using non-aqueous carriers Sep, 2029 1